The Arab Drug Company

Equities

ADCI

EGS38321C013

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 23:00:00 12/05/2024 BST			5-day change	1st Jan Change
94.19 ^EGP	0.00%		0.00%	+35.27%

02-14	The Arab Drug Company Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

The Arab Drug Company Reports Its Financial Results for the Period from July 1, 2019 to September 30, 2019

November 06, 2019

The Arab Drug Company reported Its financial results for the period from July 1, 2019 to September 30, 2019. the company announced the Net profit of EGP 18,763,518 against EGP 9,752,570 a year ago.

Latest news about The Arab Drug Company

The Arab Drug Company Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-14	CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2023	11-13	CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2022	14/11/22	CI
The Arab Drug Company Reports Earnings Results for the Half Year Ended December 31, 2021	15/02/22	CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2021	15/11/21	CI
The Arab Drug Company Reports Earnings Results for the Full Year Ended June 30, 2021	01/09/21	CI
The Arab Drug Company Reports Financial Results for the Period from July 1, 2020 to March 31, 2021	19/05/21	CI
The Arab Drug Company Reports Earnings Results for the Six Months Ended December 31, 2020	11/02/21	CI
The Arab Drug Company Announces Unaudited Earnings Results for the Full Year Ended June 30, 2020	12/07/20	CI
The Arab Drug Company Reports its Financial Results for the Period from July 1, 2019 to March 31, 2020	16/05/20	CI
Arab Drug Company Announces Earnings Results for the Nine Months Ended 31 March 2020	12/04/20	CI
The Arab Drug Company Reports Its Financial Results for the Period from July 1, 2019 to September 30, 2019	06/11/19	CI
Arab Pharmaceuticals Announces Earnings Results for the Quarter Ended March 31, 2019	13/05/19	CI
Arab Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018	10/02/19	CI
Arab Pharmaceuticals Reports Earnings Results for the Quarter Ended September 30, 2018	07/11/18	CI
The Arab Drug Company Announces Cash Dividend, Payable October 28, 2018	08/10/18	CI
Arab Pharmaceuticals Reports Audited Earnings Results for Year Ended June 30, 2018	29/08/18	CI
Arab Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018	08/05/18	CI
The Arab Drug Company Reports Earnings Results for the Six Months Ended December 31, 2017	08/02/18	CI
Arab Pharmaceuticals Reports Earnings Results for the First Quarter Ended September 30, 2017	12/11/17	CI
Arab Pharmaceuticals Declares Cash Dividend, Payable on October 26, 2017	10/10/17	CI
The Arab Drug Company Reports Audited Earnings Results for the Year Ended June 30, 2017	06/09/17	CI
Arab Pharmaceuticals Reports Earnings Results for the Nine Months Ended March 31, 2017	13/05/17	CI
Arab Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2016	07/02/17	CI

Chart The Arab Drug Company

Duration

Period

More charts

Company Profile

Arab Drug Company for Pharmaceuticals and Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical and veterinary products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
THE ARAB DRUG COMPANY	+35.27%	12.01M
ELI LILLY AND COMPANY	+29.98%	682B
NOVO NORDISK A/S	+30.34%	586B
JOHNSON & JOHNSON	-3.52%	364B
MERCK & CO., INC.	+18.59%	327B
ABBVIE INC.	+4.07%	285B
ASTRAZENECA PLC	+16.21%	240B
NOVARTIS AG	+9.66%	209B
ROCHE HOLDING AG	-6.83%	203B
AMGEN INC.	+7.09%	165B

Other Pharmaceuticals